VRAY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	96.17M
Vidutinė apimtis	0
Rinkos kapitalizacija	0.00
EPS	$-0.170 ( Q1 \| 2023-05-11 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.100 (Sector) 42.63 (Industry) 0
ATR14	$0.0670 (478.57%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2023-07-15	Shah Sanket	Buy	350 000	Common Stock
2023-07-21	Shah Sanket	Sell	30 364	Common Stock
2023-07-15	Podbelski Adam Andrew	Buy	350 000	Common Stock
2023-07-17	Podbelski Adam Andrew	Sell	89 901	Common Stock
2023-07-15	Shah Sanket	Sell	0	Common Stock

INSIDER POWER
-58.69
Last 87 transactions
Buy: 4 410 866 \| Sell: 16 363 019

Tūris Koreliacija

Ilgas: -0.24 (neutral)

Trumpas: -0.72 (moderate negative)

Signal:(19.814) Neutral

ViewRay Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
NMTR	0.827

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

ViewRay Inc Koreliacija - Valiuta/Žaliavos

0.79
( moderate )

-0.33
( neutral )

0.06
( neutral )

-0.17
( neutral )

0.46
( neutral )

-0.66
( moderate negative )

ViewRay Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$0

FY	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$0

FY	2022
Pajamos:	$102.21M
Bruto pelnas:	$10.05M (9.83 %)
EPS:	$-0.600

FY	2021
Pajamos:	$70.12M
Bruto pelnas:	$335 000 (0.48 %)
EPS:	$-0.744

Financial Reports:

No articles found.

ViewRay Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ViewRay Inc

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.